RxDoctor Payments Data

Amanjit Baadh, MD

Vascular & Interventional Radiology · Roseville, MNNPI 1003061367

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 46.2% of the total. Reporting peaked in 2024 at $2,843 and has fallen 90.4% since, to $274 in 2025.

$4,944in general payments, 2019–2025

Across 30 payments — averaging $164.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Bard Peripheral Vascular, Inc.$1K
  • Medtronic$467
  • Inari Medical, Inc.$455
  • Siemens Medical Solutions USA, Inc.$149
  • Argon Medical Devices, Inc.$122
  • plus $133 from 4 others

What the payments were for

  • Consulting fees$2,25046%
  • Travel & lodging$1834%
  • Food & beverage$2,51151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,944 in reported general payments places this provider in the 60th percentile of 78 vascular & interventional radiology providers in Minnesota.

See all vascular & interventional radiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$96,959
Medicare patients
814
Services billed
1,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Varenicline Tartrate13$3,429
Cilostazol39$886
ClopidogrelClopidogrel Bisulfate32$678
Atorvastatin Calcium21$445
Rosuvastatin Calcium26$386

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Roseville

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →